Hepatocellular carcinoma: focus on different aspects of management
S Waly Raphael, Z Yangde… - International Scholarly …, 2012 - Wiley Online Library
Hepatocellular carcinoma (HCC) is the fifth most common cancer and the third cause of
cancer‐related mortality worldwide. Its incidence is clearly arising comprised by the …
cancer‐related mortality worldwide. Its incidence is clearly arising comprised by the …
The long-term benefits of nucleos (t) ide analogs in compensated HBV cirrhotic patients with no or small esophageal varices: a 12-year prospective cohort study
P Lampertico, F Invernizzi, M Viganò, A Loglio… - Journal of …, 2015 - Elsevier
Background & Aims Esophageal varices (EV) are a marker of disease severity in
compensated cirrhosis due to hepatitis B virus (HBV) which predicts also the risk of …
compensated cirrhosis due to hepatitis B virus (HBV) which predicts also the risk of …
Retracted: MicroRNA‐1271 functions as a potential tumor suppressor in hepatitis B virus–associated hepatocellular carcinoma through the AMPK signaling pathway by binding …
Y Chen, ZX Zhao, F Huang, XW Yuan… - Journal of Cellular …, 2019 - Wiley Online Library
Hepatocellular carcinoma (HCC) is mainly associated with hepatitis B virus (HBV) infection
and characterized by metastasizing and infiltrating adjacent and distant tissues. Notably …
and characterized by metastasizing and infiltrating adjacent and distant tissues. Notably …
Hepatocellular carcinoma: high hepatitis B viral load and mortality in patients treated with transarterial chemoembolization
Purpose To determine the relationship between hepatitis B virus (HBV) DNA level and the
survival of patients with hepatocellular carcinoma treated by means of transarterial …
survival of patients with hepatocellular carcinoma treated by means of transarterial …
Hepatitis B viral load predicts survival in hepatocellular carcinoma patients treated with sorafenib
S Lim, J Han, GM Kim, KH Han… - … of Gastroenterology and …, 2015 - Wiley Online Library
Abstract Background and Aim Sorafenib is now considered as a standard treatment for
advanced hepatocellular carcinoma (HCC). We evaluated the effect of hepatitis B virus …
advanced hepatocellular carcinoma (HCC). We evaluated the effect of hepatitis B virus …
[HTML][HTML] Icaritin inhibits the expression of alpha-fetoprotein in hepatitis B virus-infected hepatoma cell lines through post-transcriptional regulation
C Zhang, H Li, W Jiang, X Zhang, G Li - Oncotarget, 2016 - ncbi.nlm.nih.gov
Although it has showed that icaritin can apparently suppress growth of HCC by reducing the
level of AFP, the intrinsic mechanism remains unclear. In this study, we explored the …
level of AFP, the intrinsic mechanism remains unclear. In this study, we explored the …
Liposomal Oxymatrine in Hepatic Fibrosis Treatment: Formulation, In Vitro and In Vivo Assessment
S Zhang, J Wu, H Wang, T Wang, L Jin, D Shu… - Aaps Pharmscitech, 2014 - Springer
The aim was to develop a liposomal oxymatrine conjugating d-alpha tocopheryl
polyethylene glycol 1000 succinate (OMT-LIP) for enhanced therapeutics of hepatic fibrosis …
polyethylene glycol 1000 succinate (OMT-LIP) for enhanced therapeutics of hepatic fibrosis …
Microarray profiling shows distinct differences between primary tumors and commonly used preclinical models in hepatocellular carcinoma
Background Despite advances in therapeutics, outcomes for hepatocellular carcinoma
(HCC) remain poor and there is an urgent need for efficacious systemic therapy …
(HCC) remain poor and there is an urgent need for efficacious systemic therapy …
Percutaneous ethanol injection therapy is comparable to radiofrequency ablation in hepatocellular carcinoma smaller than 1.5 cm: A matched case–control …
Although percutaneous ethanol injection therapy (PEIT) is best indicated for patients with
small hepatocellular carcinoma (HCC), the survival advantage of PEIT needs confirmation in …
small hepatocellular carcinoma (HCC), the survival advantage of PEIT needs confirmation in …
[PDF][PDF] Effectiveness of entecavir treatment and predictive factors for virologic response
CM Preda, C Baicus, L Negreanu, L Tugui… - Rev Esp Enferm …, 2014 - researchgate.net
Introduction: Entecavir (ETV) is a potent inhibitor of hepatitis B virus (HBV) replication. In
patients adherent to treatment, virologic remission rates of> 95% can be maintained with …
patients adherent to treatment, virologic remission rates of> 95% can be maintained with …